未登录 Elacestrant in combination with abemaciclib in patients (pts) with brain metastasis (mets) from estrogen receptor-positive (ER+), HER2-negative (HER2-) breast cancer: Preliminary data from ELECTRA, an open-label, multicenter, phase Ib/II study Elacestrant与abemaciclib联合治疗雌激素受体阳性(ER+)、人表皮生长因子受体2阴性(HER2-)乳腺癌脑转移(mets)患者的初步数据:来自ELECTRA研究(一项开放标签、多中心、 Ib/II期研究)的初步数据 Ciruelos, E. M.; Hamilton, E. P.; Kim, S-B.; Im, Y-H.; Solis, E. Segui; Saenz, J. A. Garcia; Di Sanzo, A.; Lizarbe, M. Dominguez; Wasserman, T.; Theall, K. P.; Ibrahim, N. K. 分享 收藏
Outcomes of Antiviral Retreatment for Immunocompromised Hosts With Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 Polymerase Chain Reaction Positivity: A Multicenter Australian Retrospective Case Series Bond, K. A.; Dendle, C.; Guy, S.; Slavin, M. A.; Smibert, O.; Ibrahim, N.; Kinsella, P. M.; Morrissey, C. O.; Moso, M. A.; Sasadeusz, J. J. 分享 收藏
ELECTRA: An open-label, multicenter, phase 1b/2 study of elacestrant in combination with abemaciclib in patients with brain metastasis (mets) from estrogen receptor-positive (ER+), HER2-negative (HER2-) breast cancer (BC) Ibrahim, Nuhad; Kim, Sung-Bae; Lin, Nancy; Awada, Ahmad; Gil, Eva Ciruelos; Tonini, Giulia; Vallespir, Bartomeu Piza; Theall, Kathy Puvana; Hamilton, Erika 分享 收藏
The efficacy and safety of tinengotinib in patients with advanced or metastatic HR+/HER2-breast cancer or TNBC Sarina, Piha-Paul; Xu, Binghe; Fan, Ying; Yuan, Yuan; Lavasani, Sayeh; Mortimer, Joanne; Goel, Sanjay; Tsimberidou, Apostolia; Ibrahim, Nuhad; Abouharb, Sausan; Barcenas, Carlos; Lheme, Adaeze; Karp, Daniel; Ahnert, Jordi Rodon; Dumbrava, Ecaterina; Fan, Jean; Peng, Peng; Sun, Caixia; Wang, Hui; Hennessy, Katie; Fu, Ximei; Xu, Ruolan; Ni, Shumao; Wu, Frank; Meric-Bernstam, Funda 分享 收藏
Phase II study of pembrolizumab in combination with lenvatinib in patients with triple negative breast cancer (TNBC), non-small cell lung cancer (NSCLC), and other tumor types and brain metastases Dumbrava, Ecaterina E.; Montazari, Emma J.; Vu, Uyen M.; Cai, Tiantian; Altan, Mehmet; Ibrahim, Nuhad K.; Yeboa, Debra N.; Li, Jing; Lang, Frederick F.; Sanchez, Gisela; Glitza, Isabella C.; O'Brien, Barbara J.; Murthy, Rashmi K.; Wang, Jianbo; Darko, Tanisha T.; Velazquez, Denisse; Shah, Komal; Meric-Bernstam, Funda; Tawbi, Hussein; Rodon, Jordi 分享 收藏
ELECTRA: An open-label, multicenter, phase 1b/2 study of elacestrant in combination with abemaciclib in patients with brain metastasis from estrogen receptor-positive (ER+), HER2-negative (HER2-) breast cancer (BC) Hamilton, Erika; Kim, Sung-Bae; Lin, Nancy U.; Awada, Ahmad; Gil, Eva Ciruelos; Di Sanzo, Alessandro; Vallespir, Bartomeu Piza; Theall, Kathy Puyana; Ibrahim, Nuhad 分享 收藏
分享 收藏
PTEN in triple-negative breast carcinoma: protein expression and genomic alteration in pretreatment and posttreatment specimens Chen, Hui; Ding, Qingqing; Khazai, Laila; Zhao, Li; Damodaran, Senthil; Litton, Jennifer K.; Rauch, Gaiane M.; Yam, Clinton; Chang, Jeffrey T.; Seth, Sahil; Lim, Bora; Thompson, Alastair M.; Mittendorf, Elizabeth A.; Adrada, Beatriz; Virani, Kiran; White, Jason B.; Ravenberg, Elizabeth; Song, Xingzhi; Candelaria, Rosalind; Arun, Banu; Ueno, Naoto T.; Santiago, Lumarie; Saleem, Sadia; Abouharb, Sausan; Murthy, Rashmi K.; Ibrahim, Nuhad; Routbort, Mark J.; Sahin, Aysegul; Valero, Vicente; Symmans, William Fraser; Tripathy, Debu; Wang, Wei-Lien; Moulder, Stacy; Huo, Lei 分享 收藏
A phase II study of neoadjuvant atezolizumab and nab-paclitaxel in patients with anthracycline-resistant early-stage triple-negative breast cancer 对蒽环类耐药的早期三阴性乳腺癌患者进行新辅助阿特珠单抗和nab-紫杉醇的II期研究 Yam, Clinton; Mittendorf, Elizabeth A.; Garber, Haven R.; Sun, Ryan; Damodaran, Senthil; Murthy, Rashmi K.; Ramirez, David; Karuturi, Meghan; Layman, Rachel M.; Ibrahim, Nuhad; Rauch, Gaiane M.; Adrada, Beatriz E.; Candelaria, Rosalind P.; White, Jason B.; Ravenberg, Elizabeth; Clayborn, Alyson; Ding, Qing Qing; Symmans, W. Fraser; Prabhakaran, Sabitha; Thompson, Alastair M.; Valero, Vicente; Tripathy, Debu; Huo, Lei; Moulder, Stacy L.; Litton, Jennifer K. 分享 收藏
Phase 1b study of combined selinexor and eribulin for the treatment of advanced solid tumors and triple-negative breast cancer selinexor和eribulin联合治疗晚期实体瘤和三阴性乳腺癌的1b期研究 Nelson, Blessie Elizabeth; Saleem, Sadia; Damodaran, Senthil; Somaiah, Neeta; Piha-Paul, Sarina; Moore, Julia Ann; Yilmaz, Bulent; Ogbonna, Deby; Karp, Daniel D.; Ileana Dumbrava, Ecaterina; Tsimberidou, Apostolia M.; Hong, David S.; Rodon Ahnert, Jordi; Milton, Denai R.; Zheng, Xiaofeng; Booser, Daniel J.; Ibrahim, Nuhad K.; Conley, Anthony P.; Bhosale, Priya; Hernandez, Cristhiam M. Rojas M.; Tripathy, Debasish; Naing, Aung; Meric-Bernstam, Funda 分享 收藏
Clinical and Molecular Characteristics of HER2-low/zero Early Stage Triple-Negative Breast Cancer Yam, Clinton; Li, Ziyi; Korkut, Anil; Ma, Wencai; Kong, Elisabeth; Hill, Holly A.; Abbas, Hussein; Abouharb, Sausan; Adrada, Beatriz; Arun, Banu K.; Barcenas, Carlos H.; Bisen, Ajit; Booser, Daniel; Buzdar, Aman; Candelaria, Rosalind; Chen, Junjie; Clayborn, Alyson; Damodaran, Senthil; Ding, Qingqing; Garber, Haven; Hortobagyi, Gabriel N.; Hunt, Kelly K.; Ibrahim, Nuhad K.; Iheme, Adaeze; Karuturi, Meghan S.; Koenig, Kimberly; Layman, Rachel M.; Lee, Jangsoon; Litton, Jennifer K.; Mitchell, Melissa; Moscol, Giancarlo; Mouabbi, Jason; Murthy, Rashmi K.; Oke, Oluchi; Pohlmann, Paula; Ramirez, David; Ravenberg, Elizabeth; Saleem, Sadia; Teshome, Mediget; Valero, Vicente; White, Jason; Williams, Madison; Woodward, Wendy; Yajima, Chasity; Ueno, Naoto T.; Chen, Ken; Rauch, Gaiane; Huo, Lei; Tripathy, Debu 分享 收藏
ELONA: An open-label, phase 1b-2 study of elacestrant, in combination with onapristone in patients with estrogen receptor-positive, progesterone receptor-positive, HER2-negative advanced or metastatic breast cancer Hamilton, Erika; Pusztai, Lajos; Soliman, Hatem H.; Hurvitz, Sara; Grzegorzewski, Krzysztof; Habboubi, Nassir; Marreddy, Priya; Sahmoud, Tarek; Ibrahim, Nuhad 分享 收藏
A phase 1b study of neratinib with THP in metastatic and locally advanced breast cancer, and phase II study of THP followed by AC in HER2+primary inflammatory breast cancer (IBC), and neratinib with taxol followed by AC in HR+/HER2-IBC Marx, Angela N.; Kai, Megumi; Fu, Min; Murphy, Hope E.; Willey, Jie S.; Sun, Huiming; Alexander, Angela; Bassett, Roland L.; Whitman, Gary J.; Le-Petross, H. T. Carisa; Patel, Miral; Arun, Banu K.; Abouharb, Sausan; Thomas, Parijatham S.; Barcenas, Carlos H.; Ibrahim, Nuhad K.; Valero, Vicente; Ueno, Naoto T.; Layman, Rachel M.; Lim, Bora; Woodward, Wendy; Lucci, Anthony 分享 收藏
A phase Ib trial of bintrafusp alfa and eribulin in patients with metastatic triple negative breast cancer (TNBC) Damodaran, Senthil; Liu, Diane; Schwartz, Jill; Valero, Vicente; Ramirez, David; Saleem, Sadia; Ueno, Naoto T.; Ibrahim, Nuhad K.; Karuturi, Meghan S.; Murthy, Rashmi K.; Moulder, Stacy; Litton, Jennifer K. 分享 收藏
分享 收藏
A phase II study of talimogene laherparepvec for patients with inoperable locoregional recurrence of breast cancer Kai, Megumi; Marx, Angela N.; Liu, Diane D.; Shen, Yu; Gao, Hui; Reuben, James M.; Whitman, Gary; Krishnamurthy, Savitri; Ross, Merrick, I; Litton, Jennifer K.; Lim, Bora; Ibrahim, Nuhad; Kogawa, Takahiro; Ueno, Naoto T. 分享 收藏
分享 收藏
分享 收藏
Effects of systemic therapy and local therapy on outcomes of 873 breast cancer patients with metastatic breast cancer to brain:MDAnderson Cancer Center experience Gao, Chao; Wang, Fuchenchu; Suki, Dima; Strom, Eric; Li, Jing; Sawaya, Raymond; Hsu, Limin; Raghavendra, Akshara; Tripathy, Debu; Ibrahim, Nuhad K. 分享 收藏
分享 收藏